IRF9 anticorps (AA 239-389)
Aperçu rapide pour IRF9 anticorps (AA 239-389) (ABIN1817323)
Antigène
Voir toutes IRF9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 239-389
-
Specificité
- Human ISGF3 / IRF9.
-
Purification
- Affinity purified
-
Immunogène
-
A recombinant human IRF9 protein 239-389aa (BC035716).
Type of Immunogen: Recombinant protein
-
-
-
-
Indications d'application
- Approved: ELISA (1:20000 - 1:80000), IHC (1:100 - 1:500), WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for up to 1 year.
-
Date de péremption
- 12 months
-
-
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
Autre désignation
- ISGF3 / IRF9
-
Sujet
-
Name/Gene ID: IRF9
Synonyms: IRF9, Interferon regulatory factor 9, ISGF3 p48 subunit, ISGF3G, p48, IRF-9, ISGF3, ISGF-3 gamma -
ID gène
- 10379
-
UniProt
- Q00978
-
Pathways
- Signalistation JAK/STAT, Interferon-gamma Pathway, Hepatitis C
Antigène
-